Recommendation for Remdesivir for the Treatment of Severe COVID-19 Remains Weak
August 19th 2020In an article in The BMJ, a panel of international experts presented recommendations regarding the use of remdesivir in patients with severe COVID-19, despite little evidence to support such a decision.
Read More
MJH Life Sciences™ Hosts Expert-Driven 'Debating the Road Back to School' Live Webinar
August 14th 2020An expert panel discussion for clinicians on the most important factors surrounding a safe return-to-school plan, including testing, masking, social distancing, vaccine prioritization and more.
Read More